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Background
Daily intra-peritoneal injection of IL-18 for one week in
Balb/c mice led to the development of severe cardiac
hypertrophy that was accompanied by induction of fetal
gene expression. Both anatomical and molecular features
of cardiac hypertrophy were ameliorated by pan-histone
deacetylase inhibitors (HDACIs), m-carboxycinnamic
acid bis-hydroxamide (CBHA) and trichostatin A (TSA).
Materials and methods
Treatment of mice with IL-18, with or without CBHA or
TSA, caused dynamic remodeling of cardiac chromatin
as judged by altered posttranslational modifications of
the constituent histones. Administration of either TSA or
CBHA in mice, even in the presence of IL-18, induced
hyper-acetylation of histone H3 at lysine 9 demonstrating
the unique action of HDAC inhibitors. Epigenetic
changes in chromatin architecture were accompanied by
reprogramming of cardiac hypertrophy-specific gene
expression. Comparative profiles of cardiac gene expres-
sion of vehicle-treated mice with animals that received
IL-18±CBHA or TSA revealed that 184 genes were differ-
entially expressed genes (DEGs) and a subset of 38 genes
was oppositely regulated by IL-18 and TSA. In contrast,
the hearts of mice treated with IL-18 and/or CBHA eli-
cited 147 DEGs; IL-18 robustly up-regulated 58 genes
that were blocked by CBHA or IL-18+CBHA.
Results and conclusion
Ingenuity Pathway Analysis of DEGs revealed that both
HDACIs profoundly impacted a number of intracellular
signaling pathways. Global gene expression analyses of
H9c2 cardiac myocytes incubated with CBHA or TSA
for 6 and 24 hr were also carried out. We observed that
the signatures of DEGs evoked by TSA and CBHA after
6 and at 24h treatment were unique. Nevertheless, it
appeared that both HDACIs altered the course of PI3K-
PTEN-Akt/PKB, Ca
++/calmodulin and p38-ERK-MAPK-
JNK signaling pathways to regulate gene expression via
activation of Ap1, HNF4A, Myc and NFkB. Informed by
the putative signaling networks deduced from the DEGs
seen in the heart, we investigated the expression of
phosphatase and tensin homolog (PTEN), a key regula-
tor of the PI3K-AKT/PKB-NFkB pathway. Both TSA
and CBHA induced robust expression of PTEN mRNA
and protein in the heart. Based on these data we con-
clude that both TSA and CBHA attenuated anatomical
and functional manifestations of IL-18-induced cardiac
hypertrophy by epigenetic induction of PTEN to selec-
tively block the PI3K-AKT/PKB-NFkB signaling.
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